AddLife AB (publ) - Asset Resilience Ratio

Latest as of December 2025: 6.40%

AddLife AB (publ) (ALIF-B) has an Asset Resilience Ratio of 6.40% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore ALIF-B asset base for the complete picture of this company's asset base.

Liquid Assets

Skr813.00 Million
≈ $87.49 Million USD Cash + Short-term Investments

Total Assets

Skr12.71 Billion
≈ $1.37 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how AddLife AB (publ)'s Asset Resilience Ratio has changed over time. See ALIF-B net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down AddLife AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AddLife AB (publ) (ALIF-B) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr813.00 Million 6.4%
Short-term Investments Skr0.00 0%
Total Liquid Assets Skr813.00 Million 6.40%

Asset Resilience Insights

  • Limited Liquidity: AddLife AB (publ) maintains only 6.40% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

AddLife AB (publ) Industry Peers by Asset Resilience Ratio

Compare AddLife AB (publ)'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Hubei Huaqiang High-Tech Co. Ltd. A
SHG:688151
Medical Instruments & Supplies 26.12%
Pegavision
TW:6491
Medical Instruments & Supplies 17.14%
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
Medical Instruments & Supplies 38.45%
Caina Technology Co. Ltd.
SHE:301122
Medical Instruments & Supplies 19.74%
IVF Hartmann Holding AG
SW:VBSN
Medical Instruments & Supplies 52.05%
Dentium
KO:145720
Medical Instruments & Supplies 1.23%
Medeon Biodesign
TWO:6499
Medical Instruments & Supplies 7.38%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%

Annual Asset Resilience Ratio for AddLife AB (publ) (2016–2025)

The table below shows the annual Asset Resilience Ratio data for AddLife AB (publ).

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 6.40% Skr813.00 Million
≈ $87.49 Million
Skr12.71 Billion
≈ $1.37 Billion
+3.86pp
2024-12-31 2.54% Skr331.00 Million
≈ $35.62 Million
Skr13.05 Billion
≈ $1.40 Billion
-0.20pp
2023-12-31 2.74% Skr349.00 Million
≈ $37.56 Million
Skr12.74 Billion
≈ $1.37 Billion
+0.58pp
2022-12-31 2.16% Skr282.00 Million
≈ $30.35 Million
Skr13.06 Billion
≈ $1.41 Billion
-0.97pp
2021-12-31 3.13% Skr331.70 Million
≈ $35.70 Million
Skr10.60 Billion
≈ $1.14 Billion
-1.83pp
2020-12-31 4.96% Skr205.80 Million
≈ $22.15 Million
Skr4.15 Billion
≈ $446.56 Million
+2.05pp
2019-12-31 2.91% Skr95.40 Million
≈ $10.27 Million
Skr3.27 Billion
≈ $352.38 Million
+0.80pp
2018-12-31 2.11% Skr56.30 Million
≈ $6.06 Million
Skr2.67 Billion
≈ $287.10 Million
+1.82pp
2017-12-31 0.29% Skr5.40 Million
≈ $581.13K
Skr1.89 Billion
≈ $203.53 Million
-0.65pp
2016-12-31 0.93% Skr14.70 Million
≈ $1.58 Million
Skr1.58 Billion
≈ $169.68 Million
--
pp = percentage points

About AddLife AB (publ)

ST:ALIF-B Sweden Medical Instruments & Supplies
Market Cap
$1.90 Billion
Skr17.64 Billion SEK
Market Cap Rank
#6506 Global
#91 in Sweden
Share Price
Skr150.40
Change (1 day)
-1.12%
52-Week Range
Skr134.60 - Skr206.80
All Time High
Skr384.58
About

AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical resear… Read more